Sign In

Bryn Williams-Jones

Drug Hunter | Applying AI and Machine Learning to real Drug Discovery | Applied Data Science and Machine Learning | Advisory Board Member (SAB) | Non-exec Board Member (NED)

Bryn Williams-Jones, a well-known commercial life sciences researcher, has made significant contributions to the field by conducting experiments at Pfizer Global R&D and leading innovative initiatives. He has also been associated with the Open PHACTS Foundation as CEO and Connected Discovery Ltd as Founder and Chief Operating Officer, successfully implementing knowledge solutions for drug discovery by connecting companies, specialists, and leading academics. With his experience in pre-competitive solutions to knowledge-based challenges facing drug discovery, Bryn is currently serving as the VP of Drug Discovery at BenevolentAI. He has been a regular contributor to publications like Nature Reviews Drug Discovery, highlighting the significance of informatics in generating actionable knowledge. His technical consulting and software production capabilities make ConnectedDiscovery a reliable partner in making impactful projects work. Bryn completed his BSc (Hons) at Liverpool John Moores University.

Highlights

Feb 15 · erudit.org
Canadian Journal of Bioethics Revue canadienne de bioéthique

Related Questions

What are Bryn Williams-Jones' key achievements in drug discovery?
How did Bryn Williams-Jones contribute to Connected Discovery Ltd?
What is Bryn Williams-Jones' educational background?
What roles has Bryn Williams-Jones held in his career?
How long has Bryn Williams-Jones been a member of the Pharma Footpath Advisory Board?
Bryn Williams-Jones
Bryn Williams-Jones, photo 1
Add to my network

Location

Canterbury, England, United Kingdom